Oncology Market size By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Radiation Therapy, Cell & Gene Therapy, Combination Therapy, Others), By Cancer Type (Prostate cancer, Lung cancer, Colon and rectal cancer, Gastric cancer, Esophageal cancer, Liver cancer, Breast cancer, Others), By Modality (Therapeutic Oncology, Diagnostic Oncology, Imaging (CT, MRI, PET), Molecular Diagnostics, Liquid Biopsy, Surgical Oncology, Others), By End Use (Hospitals, Diagnostic laboratories, Diagnostic imaging centers, Academia, Specialty clinics, Others), By Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2026–2035

Table of Content

• 1. Research Methodology and Data Source
  • 1.1. Methodology/Research Approach
  • 1.2. Market Size Estimation
  • 1.3. Market Breakdown and Data Triangulation
  • 1.4. Data Sources
  • 1.5. Secondary Sources
  • 1.6. Primary Sources
• 2. Executive Summary
  • 2.1. Taxonomy
  • 2.2. Global Market Outlook
  • 2.3. Key Facts and Figures
  • 2.4. Major Players in Oncology Market
• 3. Global Market Overview
  • 3.1. Industry Overview
  • 3.2. Segmental Overview
  • 3.3. Regional Overview
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
    • 3.4.4. Trends
  • 3.5. Regulatory Framework
  • 3.6. Opportunity Map Analysis
  • 3.7. Opportunity Orbits
  • 3.8. Market Investment Feasibility Index
  • 3.9. PESTLE Analysis
  • 3.10. PORTER’S Five Force Analysis
  • 3.11. Drivers & Restraints Impact Analysis
  • 3.12. Patient Journey Mapping
  • 3.13. Technological Landscape
  • 3.14. Product Life Cycle Analysis
  • 3.15. Value Chain Analysis
    • 3.15.1. List of Raw Material Suppliers
    • 3.15.2. List of Oncology Manufacturers
    • 3.15.3. List of Dealer/Distributors
    • 3.15.4. List of Potential Customers
  • 3.16. Cost Structure Analysis
  • 3.17. Regional Market Share and BPS Analysis
• 4. Macro-economic Factors
• 5. Impact of Current Geopolitical Scenario
• 6. Global Oncology Market Analysis and Forecast, By Therapy Type
  • 6.1. Key Findings
  • 6.2. Global Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 6.2.1. Chemotherapy
    • 6.2.2. Targeted Therapy
    • 6.2.3. Immunotherapy
    • 6.2.4. Hormonal Therapy
    • 6.2.5. Radiation Therapy
    • 6.2.6. Cell & Gene Therapy
    • 6.2.7. Combination Therapy
    • 6.2.8. Others
  • 6.3. Global Oncology Market Attractiveness Analysis, By Therapy Type
• 7. Global Oncology Market Analysis and Forecast, By Cancer Type
  • 7.1. Key Findings
  • 7.2. Global Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 7.2.1. Prostate cancer
    • 7.2.2. Lung cancer
    • 7.2.3. Colon and rectal cancer
    • 7.2.4. Gastric cancer
    • 7.2.5. Esophageal cancer
    • 7.2.6. Liver cancer
    • 7.2.7. Breast cancer
    • 7.2.8. Others
  • 7.3. Global Oncology Market Attractiveness Analysis, By Cancer Type
• 8. Global Oncology Market Analysis and Forecast, By Modality
  • 8.1. Key Findings
  • 8.2. Global Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 8.2.1. Therapeutic Oncology
    • 8.2.2. Diagnostic Oncology
    • 8.2.3. Imaging (CT, MRI, PET)
    • 8.2.4. Molecular Diagnostics
    • 8.2.5. Liquid Biopsy
    • 8.2.6. Surgical Oncology
    • 8.2.7. Others
  • 8.3. Global Oncology Market Attractiveness Analysis, By Modality
• 9. Global Oncology Market Analysis and Forecast, By End Use
  • 9.1. Key Findings
  • 9.2. Global Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 9.2.1. Hospitals
    • 9.2.2. Diagnostic laboratories
    • 9.2.3. Diagnostic imaging centres
    • 9.2.4. Academia
    • 9.2.5. Specialty clinics
    • 9.2.6. Others
  • 9.3. Global Oncology Market Attractiveness Analysis, By End Use
• 10. Global Oncology Market Analysis and Forecast, By Region
  • 10.1. Key Findings
  • 10.2. Global Oncology Market Size Value (US$ Bn) Forecast, By Region, 2020-2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Middle East & Africa
    • 10.2.5. Latin America
  • 10.3. Global Oncology Market Attractiveness Analysis, By Region
• 11. North America Oncology Market Analysis and Forecast, 2020-2035
  • 11.1. Key Findings
  • 11.2. North America Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • 11.3. North America Oncology Market Attractiveness Analysis, By Therapy Type
  • 11.4. North America Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
  • 11.5. North America Oncology Market Attractiveness Analysis, By Cancer Type
  • 11.6. North America Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
  • 11.7. North America Oncology Market Attractiveness Analysis, By Modality
  • 11.8. North America Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
  • 11.9. North America Oncology Market Attractiveness Analysis, By End Use
  • 11.10. North America Oncology Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 11.11. North America Oncology Market Attractiveness Analysis, By Country
    • 11.11.1. The US Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 11.11.2. The US Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 11.11.3. The US Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 11.11.4. The US Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 11.11.5. Canada Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 11.11.6. Canada Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 11.11.7. Canada Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 11.11.8. Canada Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
• 12. Europe Oncology Market Analysis and Forecast, 2020-2035
  • 12.1. Key Findings
  • 12.2. Europe Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • 12.3. Europe Oncology Market Attractiveness Analysis, By Therapy Type
  • 12.4. Europe Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
  • 12.5. Europe Oncology Market Attractiveness Analysis, By Cancer Type
  • 12.6. Europe Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
  • 12.7. Europe Oncology Market Attractiveness Analysis, By Modality
  • 12.8. Europe Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
  • 12.9. Europe Oncology Market Attractiveness Analysis, By End Use
  • 12.10. Europe Oncology Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 12.11. Europe Oncology Market Attractiveness Analysis, By Country
    • 12.11.1. Germany Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 12.11.2. Germany Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 12.11.3. Germany Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 12.11.4. Germany Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 12.11.5. The U.K. Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 12.11.6. The U.K. Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 12.11.7. The U.K. Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 12.11.8. The U.K. Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 12.11.9. France Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 12.11.10. France Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 12.11.11. France Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 12.11.12. France Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 12.11.13. Spain Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 12.11.14. Spain Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 12.11.15. Spain Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 12.11.16. Spain Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 12.11.17. Italy Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 12.11.18. Italy Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 12.11.19. Italy Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 12.11.20. Italy Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 12.11.21. Russia & CIS Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 12.11.22. Russia & CIS Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 12.11.23. Russia & CIS Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 12.11.24. Russia & CIS Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 12.11.25. Rest of Europe Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 12.11.26. Rest of Europe Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 12.11.27. Rest of Europe Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 12.11.28. Rest of Europe Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
• 13. Asia Pacific Oncology Market Analysis and Forecast, 2020-2035
  • 13.1. Key Findings
  • 13.2. Asia Pacific Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • 13.3. Asia Pacific Oncology Market Attractiveness Analysis, By Therapy Type
  • 13.4. Asia Pacific Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
  • 13.5. Asia Pacific Oncology Market Attractiveness Analysis, By Cancer Type
  • 13.6. Asia Pacific Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
  • 13.7. Asia Pacific Oncology Market Attractiveness Analysis, By Modality
  • 13.8. Asia Pacific Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
  • 13.9. Asia Pacific Oncology Market Attractiveness Analysis, By End Use
  • 13.10. Asia Pacific Oncology Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 13.11. Asia Pacific Oncology Market Attractiveness Analysis, By Country
    • 13.11.1. China Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 13.11.2. China Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 13.11.3. China Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 13.11.4. China Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 13.11.5. India Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 13.11.6. India Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 13.11.7. India Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 13.11.8. India Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 13.11.9. Japan Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 13.11.10. Japan Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 13.11.11. Japan Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 13.11.12. Japan Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 13.11.13. South Korea Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 13.11.14. South Korea Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 13.11.15. South Korea Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 13.11.16. South Korea Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 13.11.17. ASEAN Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 13.11.18. ASEAN Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 13.11.19. ASEAN Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 13.11.20. ASEAN Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 13.11.21. Australia & New Zealand Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 13.11.22. Australia & New Zealand Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 13.11.23. Australia & New Zealand Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 13.11.24. Australia & New Zealand Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 13.11.25. Rest of Asia Pacific Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 13.11.26. Rest of Asia Pacific Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 13.11.27. Rest of Asia Pacific Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 13.11.28. Rest of Asia Pacific Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
• 14. Middle East & Africa Oncology Market Analysis and Forecast, 2020-2035
  • 14.1. Key Findings
  • 14.2. Middle East & Africa Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • 14.3. Middle East & Africa Oncology Market Attractiveness Analysis, By Therapy Type
  • 14.4. Middle East & Africa Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
  • 14.5. Middle East & Africa Oncology Market Attractiveness Analysis, By Cancer Type
  • 14.6. Middle East & Africa Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
  • 14.7. Middle East & Africa Oncology Market Attractiveness Analysis, By Modality
  • 14.8. Middle East & Africa Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
  • 14.9. Middle East & Africa Oncology Market Attractiveness Analysis, By End Use
  • 14.10. Middle East & Africa Oncology Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 14.11. Middle East & Africa Oncology Market Attractiveness Analysis, By Country
    • 14.11.1. GCC Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 14.11.2. GCC Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 14.11.3. GCC Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 14.11.4. GCC Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 14.11.5. South Africa Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 14.11.6. South Africa Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 14.11.7. South Africa Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 14.11.8. South Africa Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 14.11.9. Rest of Middle East & Africa Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 14.11.10. Rest of Middle East & Africa Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 14.11.11. Rest of Middle East & Africa Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 14.11.12. Rest of Middle East & Africa Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
• 15. Latin America Oncology Market Analysis and Forecast, 2020-2035
  • 15.1. Key Findings
  • 15.2. Latin America Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • 15.3. Latin America Oncology Market Attractiveness Analysis, By Therapy Type
  • 15.4. Latin America Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
  • 15.5. Latin America Oncology Market Attractiveness Analysis, By Cancer Type
  • 15.6. Latin America Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
  • 15.7. Latin America Oncology Market Attractiveness Analysis, By Modality
  • 15.8. Latin America Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
  • 15.9. Latin America Oncology Market Attractiveness Analysis, By End Use
  • 15.10. Latin America Oncology Market Size Value (US$ Bn) Forecast, By Country, 2020-2035
  • 15.11. Latin America Oncology Market Attractiveness Analysis, By Country
    • 15.11.1. Brazil Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 15.11.2. Brazil Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 15.11.3. Brazil Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 15.11.4. Brazil Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 15.11.5. Mexico Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 15.11.6. Mexico Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 15.11.7. Mexico Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 15.11.8. Mexico Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
    • 15.11.9. Rest of Latin America Oncology Market Size Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
    • 15.11.10. Rest of Latin America Oncology Market Size Value (US$ Bn) Forecast, By Cancer Type, 2020-2035
    • 15.11.11. Rest of Latin America Oncology Market Size Value (US$ Bn) Forecast, By Modality, 2020-2035
    • 15.11.12. Rest of Latin America Oncology Market Size Value (US$ Bn) Forecast, By End Use, 2020-2035
• 16. Competitive Landscape & Company Profiles
  • 16.1. Market Competition Scenario Analysis, By Company
  • 16.2. Competitor Landscape
  • 16.3. Company Share Analysis
  • 16.4. Company Profiles
    • 16.4.1. Bristol-Myers Squibb Company.
      • 16.4.1.1. Company Details
      • 16.4.1.2. Business Overview
      • 16.4.1.3. Product Portfolio
      • 16.4.1.4. Financial Insights
      • 16.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.1.6. SWOT Analysis
      • 16.4.1.7. Geographic Footprint
    • 16.4.2. Amgen Inc.
      • 16.4.2.1. Company Details
      • 16.4.2.2. Business Overview
      • 16.4.2.3. Product Portfolio
      • 16.4.2.4. Financial Insights
      • 16.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.2.6. SWOT Analysis
      • 16.4.2.7. Geographic Footprint
    • 16.4.3. AstraZeneca plc.
      • 16.4.3.1. Company Details
      • 16.4.3.2. Business Overview
      • 16.4.3.3. Product Portfolio
      • 16.4.3.4. Financial Insights
      • 16.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.3.6. SWOT Analysis
      • 16.4.3.7. Geographic Footprint
    • 16.4.4. Gilead Sciences, Inc.
      • 16.4.4.1. Company Details
      • 16.4.4.2. Business Overview
      • 16.4.4.3. Product Portfolio
      • 16.4.4.4. Financial Insights
      • 16.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.4.6. SWOT Analysis
      • 16.4.4.7. Geographic Footprint
    • 16.4.5. Eli Lilly and Company.
      • 16.4.5.1. Company Details
      • 16.4.5.2. Business Overview
      • 16.4.5.3. Product Portfolio
      • 16.4.5.4. Financial Insights
      • 16.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.5.6. SWOT Analysis
      • 16.4.5.7. Geographic Footprint
    • 16.4.6. GE Healthcare Technologies Inc.
      • 16.4.6.1. Company Details
      • 16.4.6.2. Business Overview
      • 16.4.6.3. Product Portfolio
      • 16.4.6.4. Financial Insights
      • 16.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.6.6. SWOT Analysis
      • 16.4.6.7. Geographic Footprint
    • 16.4.7. AbbVie Inc.
      • 16.4.7.1. Company Details
      • 16.4.7.2. Business Overview
      • 16.4.7.3. Product Portfolio
      • 16.4.7.4. Financial Insights
      • 16.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.7.6. SWOT Analysis
      • 16.4.7.7. Geographic Footprint
    • 16.4.8. GlaxoSmithKline plc.
      • 16.4.8.1. Company Details
      • 16.4.8.2. Business Overview
      • 16.4.8.3. Product Portfolio
      • 16.4.8.4. Financial Insights
      • 16.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.8.6. SWOT Analysis
      • 16.4.8.7. Geographic Footprint
    • 16.4.9. Johnson & Johnson Services, Inc.
      • 16.4.9.1. Company Details
      • 16.4.9.2. Business Overview
      • 16.4.9.3. Product Portfolio
      • 16.4.9.4. Financial Insights
      • 16.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.9.6. SWOT Analysis
      • 16.4.9.7. Geographic Footprint
    • 16.4.10. Merck & Co., Inc.
      • 16.4.10.1. Company Details
      • 16.4.10.2. Business Overview
      • 16.4.10.3. Product Portfolio
      • 16.4.10.4. Financial Insights
      • 16.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.10.6. SWOT Analysis
      • 16.4.10.7. Geographic Footprint
    • 16.4.11. Novartis AG.
      • 16.4.11.1. Company Details
      • 16.4.11.2. Business Overview
      • 16.4.11.3. Product Portfolio
      • 16.4.11.4. Financial Insights
      • 16.4.11.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.11.6. SWOT Analysis
      • 16.4.11.7. Geographic Footprint
    • 16.4.12. Pfizer Inc.
      • 16.4.12.1. Company Details
      • 16.4.12.2. Business Overview
      • 16.4.12.3. Product Portfolio
      • 16.4.12.4. Financial Insights
      • 16.4.12.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.12.6. SWOT Analysis
      • 16.4.12.7. Geographic Footprint
    • 16.4.13. Hoffmann-La Roche Ltd.
      • 16.4.13.1. Company Details
      • 16.4.13.2. Business Overview
      • 16.4.13.3. Product Portfolio
      • 16.4.13.4. Financial Insights
      • 16.4.13.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.13.6. SWOT Analysis
      • 16.4.13.7. Geographic Footprint
    • 16.4.14. Sanofi S.A.
      • 16.4.14.1. Company Details
      • 16.4.14.2. Business Overview
      • 16.4.14.3. Product Portfolio
      • 16.4.14.4. Financial Insights
      • 16.4.14.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.14.6. SWOT Analysis
      • 16.4.14.7. Geographic Footprint
    • 16.4.15. Takeda Pharmaceutical Company Limited.
      • 16.4.15.1. Company Details
      • 16.4.15.2. Business Overview
      • 16.4.15.3. Product Portfolio
      • 16.4.15.4. Financial Insights
      • 16.4.15.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 16.4.15.6. SWOT Analysis
      • 16.4.15.7. Geographic Footprint

List of Tables

• Table 1: Global Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 2: Global Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 3: Global Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 4: Global Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 5: Global Oncology Market Value (US$ Bn), By Region, 2020-2035
• Table 6: North America Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 7: North America Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 8: North America Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 9: North America Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 10: North America Oncology Market Value (US$ Bn), By Country, 2020-2035
• Table 11: The US Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 12: The US Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 13: The US Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 14: The US Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 15: Canada Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 16: Canada Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 17: Canada Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 18: Canada Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 19: Europe Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 20: Europe Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 21: Europe Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 22: Europe Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 23: Europe Oncology Market Value (US$ Bn), By Country, 2020-2035
• Table 24: Germany Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 25: Germany Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 26: Germany Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 27: Germany Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 28: The U.K. Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 29: The U.K. Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 30: The U.K. Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 31: The U.K. Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 32: France Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 33: France Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 34: France Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 35: France Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 36: Spain Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 37: Spain Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 38: Spain Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 39: Spain Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 40: Italy Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 41: Italy Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 42: Italy Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 43: Italy Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 44: Russia & CIS Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 45: Russia & CIS Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 46: Russia & CIS Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 47: Russia & CIS Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 48: Rest of Europe Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 49: Rest of Europe Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 50: Rest of Europe Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 51: Rest of Europe Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 52: Asia Pacific Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 53: Asia Pacific Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 54: Asia Pacific Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 55: Asia Pacific Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 56: Asia Pacific Oncology Market Value (US$ Bn), By Country, 2020-2035
• Table 57: China Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 58: China Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 59: China Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 60: China Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 61: India Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 62: India Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 63: India Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 64: India Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 65: Japan Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 66: Japan Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 67: Japan Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 68: Japan Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 69: South Korea Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 70: South Korea Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 71: South Korea Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 72: South Korea Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 73: ASEAN Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 74: ASEAN Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 75: ASEAN Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 76: ASEAN Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 77: Australia & New Zealand Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 78: Australia & New Zealand Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 79: Australia & New Zealand Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 80: Australia & New Zealand Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 81: Rest of Asia Pacific Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 82: Rest of Asia Pacific Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 83: Rest of Asia Pacific Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 84: Rest of Asia Pacific Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 85: Middle East & Africa Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 86: Middle East & Africa Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 87: Middle East & Africa Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 88: Middle East & Africa Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 89: Middle East & Africa Oncology Market Value (US$ Bn), By Country, 2020-2035
• Table 90: GCC Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 91: GCC Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 92: GCC Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 93: GCC Oncology Market Value (US$ Bn),By End Use, 2020-2035
• Table 94: South Africa Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 95: South Africa Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 96: South Africa Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 97: South Africa Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 98: Rest of Middle East & Africa Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 99: Rest of Middle East & Africa Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 100: Rest of Middle East & Africa Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 101: Rest of Middle East & Africa Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 102: Latin America Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 103: Latin America Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 104: Latin America Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 105: Latin America Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 106: Latin America Oncology Market Value (US$ Bn), By Country, 2020-2035
• Table 107: Brazil Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 108: Brazil Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 109: Brazil Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 110: Brazil Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 111: Mexico Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 112: Mexico Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 113: Mexico Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 114: Mexico Oncology Market Value (US$ Bn), By End Use, 2020-2035
• Table 115: Rest of Latin America Oncology Market Value (US$ Bn), By Therapy Type, 2020-2035
• Table 116: Rest of Latin America Oncology Market Value (US$ Bn), By Cancer Type, 2020-2035
• Table 117: Rest of Latin America Oncology Market Value (US$ Bn), By Modality, 2020-2035
• Table 118: Rest of Latin America Oncology Market Value (US$ Bn), By End Use, 2020-2035

List of Figures

• Figure 1: Global Oncology Market Value (US$ Bn), 2020-2035
• Figure 2: Global Oncology Market Value Share (%) Analysis, By Therapy Type, 2025 & 2035
• Figure 3: Global Oncology Market Value Share (%) Analysis, By Cancer Type, 2025 & 2035
• Figure 4: Global Oncology Market Value Share (%) Analysis, By Modality, 2025 & 2035
• Figure 5: Global Oncology Market Value Share (%) Analysis, By End Use, 2025 & 2035
• Figure 6: Global Oncology Market Value Share (%) Analysis, By Region, 2025 & 2035
• Figure 7: Global Oncology Market Value Share (%) Analysis, By Therapy Type, 2020, 2025 and 2035
• Figure 8: Global Oncology Market Attractiveness Analysis, By Therapy Type
• Figure 9: Global Oncology Market Value Share (%) Analysis, By Cancer Type, 2020, 2025 and 2035
• Figure 10: Global Oncology Market Attractiveness Analysis, By Cancer Type
• Figure 11: Global Oncology Market Value Share (%) Analysis, By Modality, 2020, 2025 and 2035
• Figure 12: Global Oncology Market Attractiveness Analysis, By Modality
• Figure 13: Global Oncology Market Value Share (%) Analysis, By End Use, 2020, 2025 and 2035
• Figure 14: Global Oncology Market Attractiveness Analysis, By End Use
• Figure 15: Global Oncology Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
• Figure 16: Global Oncology Market Attractiveness Analysis, By Region
• Figure 17: North America Oncology Market Value Share (%) Analysis, By Therapy Type, 2020, 2025 and 2035
• Figure 18: North America Oncology Market Attractiveness Analysis, By Therapy Type
• Figure 19: North America Oncology Market Value Share (%) Analysis, By Cancer Type, 2020, 2025 and 2035
• Figure 20: North America Oncology Market Attractiveness Analysis, By Cancer Type
• Figure 21: North America Oncology Market Value Share (%) Analysis, By Modality, 2020, 2025 and 2035
• Figure 22: North America Oncology Market Attractiveness Analysis, By Modality
• Figure 23: North America Oncology Market Value Share (%) Analysis, By End Use, 2020, 2025 and 2035
• Figure 24: North America Oncology Market Attractiveness Analysis, By End Use
• Figure 25: North America Oncology Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 26: North America Oncology Market Attractiveness Analysis, By Country
• Figure 27: Europe Oncology Market Value Share (%) Analysis, By Therapy Type, 2020, 2025 and 2035
• Figure 28: Europe Oncology Market Attractiveness Analysis, By Therapy Type
• Figure 29: Europe Oncology Market Value Share (%) Analysis, By Cancer Type, 2020, 2025 and 2035
• Figure 30: Europe Oncology Market Attractiveness Analysis, By Cancer Type
• Figure 31: Europe Oncology Market Value Share (%) Analysis, By Modality, 2020, 2025 and 2035
• Figure 32: Europe Oncology Market Attractiveness Analysis, By Modality
• Figure 33: Europe Oncology Market Value Share (%) Analysis, By End Use, 2020, 2025 and 2035
• Figure 34: Europe Oncology Market Attractiveness Analysis, By End Use
• Figure 35: Europe Oncology Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 36: Europe Oncology Market Attractiveness Analysis, By Country
• Figure 37: Asia Pacific Oncology Market Value Share (%) Analysis, By Therapy Type, 2020, 2025 and 2035
• Figure 38: Asia Pacific Oncology Market Attractiveness Analysis, By Therapy Type
• Figure 39: Asia Pacific Oncology Market Value Share (%) Analysis, By Cancer Type, 2020, 2025 and 2035
• Figure 40: Asia Pacific Oncology Market Attractiveness Analysis, By Cancer Type
• Figure 41: Asia Pacific Oncology Market Value Share (%) Analysis, By Modality, 2020, 2025 and 2035
• Figure 42: Asia Pacific Oncology Market Attractiveness Analysis, By Modality
• Figure 43: Asia Pacific Oncology Market Value Share (%) Analysis, By End Use, 2020, 2025 and 2035
• Figure 44: Asia Pacific Oncology Market Attractiveness Analysis, By End Use
• Figure 45: Asia Pacific Oncology Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 46: Asia Pacific Oncology Market Attractiveness Analysis, By Country
• Figure 47: Middle East & Africa Oncology Market Value Share (%) Analysis, By Therapy Type, 2020, 2025 and 2035
• Figure 48: Middle East & Africa Oncology Market Attractiveness Analysis, By Therapy Type
• Figure 49: Middle East & Africa Oncology Market Value Share (%) Analysis, By Cancer Type, 2020, 2025 and 2035
• Figure 50: Middle East & Africa Oncology Market Attractiveness Analysis, By Cancer Type
• Figure 51: Middle East & Africa Oncology Market Value Share (%) Analysis, By Modality, 2020, 2025 and 2035
• Figure 52: Middle East & Africa Oncology Market Attractiveness Analysis, By Modality
• Figure 53: Middle East & Africa Oncology Market Value Share (%) Analysis, By End Use, 2020, 2025 and 2035
• Figure 54: Middle East & Africa Oncology Market Attractiveness Analysis, By End Use
• Figure 55: Middle East & Africa Oncology Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 56: Middle East & Africa Oncology Market Attractiveness Analysis, By Country
• Figure 57: Latin America Oncology Market Value Share (%) Analysis, By Therapy Type, 2020, 2025 and 2035
• Figure 58: Latin America Oncology Market Attractiveness Analysis, By Therapy Type
• Figure 59: Latin America Oncology Market Value Share (%) Analysis, By Cancer Type, 2020, 2025 and 2035
• Figure 60: Latin America Oncology Market Attractiveness Analysis, By Cancer Type
• Figure 61: Latin America Oncology Market Value Share (%) Analysis, By Modality, 2020, 2025 and 2035
• Figure 62: Latin America Oncology Market Attractiveness Analysis, By Modality
• Figure 63: Latin America Oncology Market Value Share (%) Analysis, By End Use, 2020, 2025 and 2035
• Figure 64: Latin America Oncology Market Attractiveness Analysis, By End Use
• Figure 65: Latin America Oncology Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 66: Latin America Oncology Market Attractiveness Analysis, By Country